MEDICAL AFFAIRS EFFICIENCY IN PHARMA – A PRAGMATIC APPROACH TO SUCCESS

Detalhes bibliográficos
Autor(a) principal: Dias, José Aleixo
Data de Publicação: 2014
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.25756/rpf.v6i4.21
Resumo: Along recent years Pharma operations became increasingly complex. Trying to adapt to the requests of a fast changing and demanding environment, companies moved from the standard medical, marketing and sales structure to a much more complex puzzle of units, departments, internal and external reporting lines. Along with these, the number of functions increased so much that titles became confused for customers as for colleagues. The number of systems and tools grew alike; some are useful while others not compatible or redundant. The medical structure which was minimal two decades ago, increased to meet the requirements for scientific evidence, both from prescribers and payers. The roles of these medical affairs (MA) functions, the way these are organized, the processes of interaction with other relevant players, their contribution to capture insights and translate these into actions, their reporting lines and the impact generated for the business and to the customers, are very much under discussion. Companies have been adopting different models to respond to these needs, but the change is constant, showing that most probably, the best fit has not yet been reached. The customer facing medical is a natural strategic evolution of the traditional MA role, demonstrating value, business alignment, integration and governance, which are essential pillars in building customer partnerships. This article describes the situation, and discusses pragmatic approaches to some of the most common challenges and issues, aiming to contribute to the improvement and effectiveness of the MA operations.
id RCAP_4f902f1ec7b3698831a275c8ae670b80
oai_identifier_str oai:ojs.farmacoterapia.pt:article/21
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str
spelling MEDICAL AFFAIRS EFFICIENCY IN PHARMA – A PRAGMATIC APPROACH TO SUCCESSMEDICAL AFFAIRS EFFICIENCY IN PHARMA – A PRAGMATIC APPROACH TO SUCCESSAlong recent years Pharma operations became increasingly complex. Trying to adapt to the requests of a fast changing and demanding environment, companies moved from the standard medical, marketing and sales structure to a much more complex puzzle of units, departments, internal and external reporting lines. Along with these, the number of functions increased so much that titles became confused for customers as for colleagues. The number of systems and tools grew alike; some are useful while others not compatible or redundant. The medical structure which was minimal two decades ago, increased to meet the requirements for scientific evidence, both from prescribers and payers. The roles of these medical affairs (MA) functions, the way these are organized, the processes of interaction with other relevant players, their contribution to capture insights and translate these into actions, their reporting lines and the impact generated for the business and to the customers, are very much under discussion. Companies have been adopting different models to respond to these needs, but the change is constant, showing that most probably, the best fit has not yet been reached. The customer facing medical is a natural strategic evolution of the traditional MA role, demonstrating value, business alignment, integration and governance, which are essential pillars in building customer partnerships. This article describes the situation, and discusses pragmatic approaches to some of the most common challenges and issues, aiming to contribute to the improvement and effectiveness of the MA operations.Along recent years Pharma operations became increasingly complex. Trying to adapt to the requests of a fast changing and demanding environment, companies moved from the standard medical, marketing and sales structure to a much more complex puzzle of units, departments, internal and external reporting lines. Along with these, the number of functions increased so much that titles became confused for customers as for colleagues. The number of systems and tools grew alike; some are useful while others not compatible or redundant. The medical structure which was minimal two decades ago, increased to meet the requirements for scientific evidence, both from prescribers and payers. The roles of these medical affairs (MA) functions, the way these are organized, the processes of interaction with other relevant players, their contribution to capture insights and translate these into actions, their reporting lines and the impact generated for the business and to the customers, are very much under discussion. Companies have been adopting different models to respond to these needs, but the change is constant, showing that most probably, the best fit has not yet been reached. The customer facing medical is a natural strategic evolution of the traditional MA role, demonstrating value, business alignment, integration and governance, which are essential pillars in building customer partnerships. This article describes the situation, and discusses pragmatic approaches to some of the most common challenges and issues, aiming to contribute to the improvement and effectiveness of the MA operations.Formifarma2014-12-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.25756/rpf.v6i4.21https://doi.org/10.25756/rpf.v6i4.21Revista Portuguesa de Farmacoterapia / Portuguese Journal of Pharmacotherapy; Vol 6 No 4 (2014): Outubro; 14-25Revista Portuguesa de Farmacoterapia; v. 6 n. 4 (2014): Outubro; 14-252183-73411647-354Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://revista.farmacoterapia.pt/index.php/rpf/article/view/21http://revista.farmacoterapia.pt/index.php/rpf/article/view/21/16Direitos de Autor (c) 2017 Revista Portuguesa de Farmacoterapiahttp://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessDias, José Aleixo2023-09-01T04:32:58ZPortal AgregadorONG
dc.title.none.fl_str_mv MEDICAL AFFAIRS EFFICIENCY IN PHARMA – A PRAGMATIC APPROACH TO SUCCESS
MEDICAL AFFAIRS EFFICIENCY IN PHARMA – A PRAGMATIC APPROACH TO SUCCESS
title MEDICAL AFFAIRS EFFICIENCY IN PHARMA – A PRAGMATIC APPROACH TO SUCCESS
spellingShingle MEDICAL AFFAIRS EFFICIENCY IN PHARMA – A PRAGMATIC APPROACH TO SUCCESS
Dias, José Aleixo
title_short MEDICAL AFFAIRS EFFICIENCY IN PHARMA – A PRAGMATIC APPROACH TO SUCCESS
title_full MEDICAL AFFAIRS EFFICIENCY IN PHARMA – A PRAGMATIC APPROACH TO SUCCESS
title_fullStr MEDICAL AFFAIRS EFFICIENCY IN PHARMA – A PRAGMATIC APPROACH TO SUCCESS
title_full_unstemmed MEDICAL AFFAIRS EFFICIENCY IN PHARMA – A PRAGMATIC APPROACH TO SUCCESS
title_sort MEDICAL AFFAIRS EFFICIENCY IN PHARMA – A PRAGMATIC APPROACH TO SUCCESS
author Dias, José Aleixo
author_facet Dias, José Aleixo
author_role author
dc.contributor.author.fl_str_mv Dias, José Aleixo
description Along recent years Pharma operations became increasingly complex. Trying to adapt to the requests of a fast changing and demanding environment, companies moved from the standard medical, marketing and sales structure to a much more complex puzzle of units, departments, internal and external reporting lines. Along with these, the number of functions increased so much that titles became confused for customers as for colleagues. The number of systems and tools grew alike; some are useful while others not compatible or redundant. The medical structure which was minimal two decades ago, increased to meet the requirements for scientific evidence, both from prescribers and payers. The roles of these medical affairs (MA) functions, the way these are organized, the processes of interaction with other relevant players, their contribution to capture insights and translate these into actions, their reporting lines and the impact generated for the business and to the customers, are very much under discussion. Companies have been adopting different models to respond to these needs, but the change is constant, showing that most probably, the best fit has not yet been reached. The customer facing medical is a natural strategic evolution of the traditional MA role, demonstrating value, business alignment, integration and governance, which are essential pillars in building customer partnerships. This article describes the situation, and discusses pragmatic approaches to some of the most common challenges and issues, aiming to contribute to the improvement and effectiveness of the MA operations.
publishDate 2014
dc.date.none.fl_str_mv 2014-12-30
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.25756/rpf.v6i4.21
https://doi.org/10.25756/rpf.v6i4.21
url https://doi.org/10.25756/rpf.v6i4.21
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://revista.farmacoterapia.pt/index.php/rpf/article/view/21
http://revista.farmacoterapia.pt/index.php/rpf/article/view/21/16
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2017 Revista Portuguesa de Farmacoterapia
http://creativecommons.org/licenses/by-nc-nd/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2017 Revista Portuguesa de Farmacoterapia
http://creativecommons.org/licenses/by-nc-nd/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Formifarma
publisher.none.fl_str_mv Formifarma
dc.source.none.fl_str_mv Revista Portuguesa de Farmacoterapia / Portuguese Journal of Pharmacotherapy; Vol 6 No 4 (2014): Outubro; 14-25
Revista Portuguesa de Farmacoterapia; v. 6 n. 4 (2014): Outubro; 14-25
2183-7341
1647-354X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1777301241708150784